Mesoblast (ASX:MSB) has announced that Joseph Swedish has chosen to step down as chair and will remain on the board until completion of his term at the company's annual general meeting later this year.
-
Latest News
Alterity Therapeutics presents new data demonstrating potential of ATH434
April 30, 2024 -
AusBiotech
AusMedtechInvest keynote and panel speakers announced
April 30, 2024 -
Latest News
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
April 30, 2024
-
Latest News Mesoblast announces the appointment of new board chair April 30, 2024
-
Latest News Opyl expands coverage TrialKey of clinical trial prediction and design optimisation April 30, 2024Opyl (ASX:OPL) has confirmed the recent expansion of its TrialKey.ai AI-driven platform. It says this marks a significant milestone in clinical trial prediction and design optimisation.
-
AusBiotech AusBiotech announces incoming CEO April 23, 2024Australia’s industry body for biotechnology, AusBiotech, has announced ex-Sanofi leader Rebekah Cassidy as its incoming Chief Executive Officer.
-
Latest News Osteopore launches first first-in-human clinical trials begin in Singapore April 23, 2024Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) has announced the commencement of first-in-human clinical trials for knee preservation in Singapore.
-
Latest News Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate April 23, 2024Noxopharm CEO Dr Gisela Mautner added, “We are very grateful to the Tour de Cure team for funding this promising research. With this grant, our preclinical drug candidate is recognised as having potential that warrants further investigation and development."
-
Latest News BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics April 23, 2024Bristol Myers Squibb has joined Brandon Capital, a leading Australian life sciences private equity firm, in supporting Pathios Therapeutics' Series B financing.
-
Latest News Mark Butler announces NHMRC funding for six telehealth research projects April 23, 2024The Albanese Government has announced that the National Health and Medical Research Council will invest $5 million in six research projects focused on telehealth.
-
Latest News MTPConnect says Australia poised to lead revolution in radiopharmaceuticals April 18, 2024MTPConnect says a new discussion paper reveals how Australia is ready to play a leading role in the rise of the global radiopharmaceutical industry.
-
Latest News Telix Pharmaceuticals records another quarter of strong revenue growth April 18, 2024Telix Pharmaceuticals (ASX:TLX) has reported an 18 per cent increase in revenue for the first three months of the calendar year 2024.
-
Latest News Immutep appoints research institute to conduct first-in-human study of IMP761 April 18, 2024Immutep Limited (ASX:IMM) has entered into an agreement with the Centre for Human Drug Research (CHDR) in the Netherlands to perform a first-in-human clinical study of IMP761.
-
Latest News Bioxyne receives commitments to raise funds to further product development April 18, 2024Australian life sciences, pharmaceutical and consumer health products company Bioxyne (ASX:BXN) has received firm commitments to raise $1.45 million.
-
Latest News Seaport Therapeutics receives $100 million in funding to maximise Monash invention April 16, 2024US clinical-stage biopharmaceutical company Seaport Therapeutics has closed a US$100 million oversubscribed Series A financing round to progress a pipeline using a platform developed at the Monash Institute of Pharmaceutical Sciences.
-
AusBiotech AusBiotech welcomes the Medical Science Co-Investment Plan April 16, 2024The Australian Government has launched its Medical Science Co-Investment Plan, identifying four key investment opportunity areas in the medical science priority area: medical devices, complex therapeutics, digital health, and sustainability.
-
Latest News Telix's TLX101-CDx granted fast track designation by US FDA April 16, 2024The US FDA has granted fast-track designation to Telix Pharmaceuticals (ASX:TLX) investigational glioma imaging product Pixclara (TLX101-CDx).
-
Latest News First Turkish patient treated with OncoSil cancer treatment device April 16, 2024Pancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has announced the first treatment utilising the OncoSil device on a patient residing in Turkey.
-
Latest News dorsaVi enters aged care market with proprietary ‘natural movement’ AI algorithm April 16, 2024dorsaVi CEO Dr Andrew Ronchi said, “I am delighted to announce the release of our Natural Movement Algorithm which will drive new commercial applications within the aged care sector domestically and internationally."
-
Latest News Next Science says study shows efficacy in reducing infection when used in knee arthroplasty April 16, 2024Next Science (ASX:NXS) has announced the publication of a study it says demonstrates the efficacy of XPERIENCE in decreasing periprosthetic joint infection following a Total Knee Arthroplasty.
New Stories
-
AusMedtechInvest keynote and panel speakers announced
April 30, 2024 - - AusBiotech -
Mesoblast announces the appointment of new board chair
April 30, 2024 - - Latest News -
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
April 30, 2024 - - Latest News -
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
April 30, 2024 - - Latest News -
Alterity Therapeutics presents new data demonstrating potential of ATH434
April 30, 2024 - - Latest News -
AusBiotech announces incoming CEO
April 23, 2024 - - AusBiotech -
Osteopore launches first first-in-human clinical trials begin in Singapore
April 23, 2024 - - Latest News